GPL Holdings, Inc. (GPLL) stock
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Oct 31, 2023
Valuation
- Market cap
- $2.56M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$55.58K
- EPS, diluted
- $0.00
- Book value per share
- -$0.00
- Diluted shares
- 227M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 0
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | GPLL | S&P 500 | Difference | GPLL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | -38.9% | +3.4% | −42.3 pts | ||
| Year to date | -66.2% | +13.3% | −79.4 pts | ||
| 1 year | -71.8% | +16.6% | −88.4 pts | ||
| 3 years | -71.8% | +86.4% | −158.1 pts | -34.4% | +23.1% |
Three years at a glance
Fiscal years 2021 to 2023 and trailing twelve months, USD
Net income
EPS, diluted
Press releases
Releases GPL filed with the SEC as exhibits to Form 8-K or 6-K
About GPL
Blank Checks
GPL Holdings, Inc. is a biopharmaceutical company engaged in developing novel therapies and supplying affordable healthcare items, including prescription and over-the-counter pharmaceuticals, medical and dental equipment, and healthcare supplies. Operating through its subsidiary, Global Pharma Labs, Inc., the company focuses on advancing its preclinical osteoarthritis therapy, OA-sys, toward clinical trials. In addition, it develops medication therapies targeting conditions such as onychomycosis, erectile dysfunction, cold sores, shingles, and genital herpes. The enterprise aims to serve healthcare consumers and distribution channels requiring affordable treatment options.
Company profile, executives and historyGPL stock: common questions
What is GPL's stock price?
GPLL closed at $0.01 on Oct 19, 2026, up 0.00% on the day.
What is GPL's market cap?
GPL was worth $2.56M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is GPLL's P/E ratio?
GPL lost money over the twelve months to Oct 31, 2023 (diluted EPS $0.00), so it has no meaningful P/E ratio.
Does GPL pay a dividend?
No. GPL has not paid a cash dividend over the last twelve months.
How has GPLL stock performed over the past year?
Including dividends, GPLL returned -71.8% over the past year, against +16.6% for the S&P 500.
Who are GPL's competitors?
Companies most similar to GPL by business, industry and size include OACC, AFJK, LPAA, SORN, DMII.
See a number that looks wrong?